Edition:
United States

Inflarx NV (IFRX.OQ)

IFRX.OQ on NASDAQ Stock Exchange Global Select Market

35.00USD
3:07pm EDT
Change (% chg)

$0.89 (+2.61%)
Prev Close
$34.11
Open
$34.26
Day's High
$35.49
Day's Low
$34.21
Volume
15,064
Avg. Vol
16,555
52-wk High
$42.79
52-wk Low
$14.50

Chart for

About

Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory... (more)

Overall

Beta: --
Market Cap(Mil.): $863.40
Shares Outstanding(Mil.): 25.31
Dividend: --
Yield (%): --

Financials

  IFRX.OQ Industry Sector
P/E (TTM): -- 243.17 32.94
EPS (TTM): -1.46 -- --
ROI: -- -7.30 12.79
ROE: -- -10.05 14.67

BRIEF-Inflarx Announces First Patient Enrolled In Phase Iib Trial With Lead Candidate Ifx-1 In Hidradenitis Suppurativa

* INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA Source text for Eikon: Further company coverage:

Mar 08 2018

BRIEF-Inflarx Receives IND Acceptance To Proceed With A Phase IIB Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa

* INFLARX RECEIVES IND ACCEPTANCE TO PROCEED WITH A PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA

Jan 09 2018

BRIEF-Ra Capital Management Reports 12.3 Pct Passive Stake In Inflarx Nv

* RA CAPITAL MANAGEMENT LLC REPORTS 12.3 PERCENT PASSIVE STAKE IN INFLARX NV AS OF NOVEMBER 8 - SEC FILING Source text: [http://bit.ly/2kmho2j] Further company coverage:

Dec 11 2017

Earnings vs. Estimates